Vir Biotechnology, Inc. Annual Nonoperating Income (Expense) in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Vir Biotechnology, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2017 to 2023.
  • Vir Biotechnology, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $17.8M, a 11.6% decline year-over-year.
  • Vir Biotechnology, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $69.8M, a 90.2% increase year-over-year.
  • Vir Biotechnology, Inc. annual Nonoperating Income (Expense) for 2023 was $56.1M.
  • Vir Biotechnology, Inc. annual Nonoperating Income (Expense) for 2022 was -$78.8M, a 161% decline from 2021.
  • Vir Biotechnology, Inc. annual Nonoperating Income (Expense) for 2021 was $129M.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $56.1M +$135M Jan 1, 2023 Dec 31, 2023 10-K 2024-02-26
2022 -$78.8M -$208M -161% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-26
2021 $129M +$131M Jan 1, 2021 Dec 31, 2021 10-K 2024-02-26
2020 -$1.63M +$1.82M +52.7% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 -$3.45M -$5.78M -248% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 $2.33M +$1.61M +223% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 $721K Jan 1, 2017 Dec 31, 2017 10-K 2020-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.